CytoMed Therapeutics Limited (GDTC)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | — |
|
| Statements | ||
| Consolidated Statements of Financial Positions | — |
|
| Consolidated Statements of Profit Or Loss and Other Comprehensive Loss | — |
|
| Consolidated Statements of Changes In Equity | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Notes | ||
| Borrowings | — |
|
| Capital Reserve | — |
|
| Cash and Bank Balances | — |
|
| Cash and Cash Equivalents | — |
|
| Commitments | — |
|
| Contract Liabilities | — |
|
| Convertible Loans | — |
|
| Critical Accounting Judgements and Key Sources of Estimation Uncertainty | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Employee Benefits Expenses | — |
|
| Events Occurring After Balance Sheet Date | — |
|
| Finance Expenses | — |
|
| Financial Assets, At Fvoci | — |
|
| Financial Instruments, Financial Risks and Capital Risks Management | — |
|
| General | — |
|
| Holding Company and Related Company Transactions | — |
|
| Income Tax Expense | — |
|
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | — |
|
| Investment In An Associate | — |
|
| Lease Liabilities | — |
|
| Material Accounting Policy Information | — |
|
| Other (losses)/gains Including Fair Value Changes On Financial Instruments | — |
|
| Other Expenses | — |
|
| Other Gains/(losses) Including Fair Value Changes On Financial Instruments Net | — |
|
| Other Operating Income | — |
|
| Other Receivables | — |
|
| Property, Plant and Equipment | — |
|
| Reconciliations of Liabilities Arising From Financing Activities | — |
|
| Related Party Transactions | — |
|
| Research Expenses | — |
|
| Revenue | — |
|
| Segment Information | — |
|
| Share Capital | — |
|
| Share Capital and Share Application Monies | — |
|
| Share-based Payment Reserve | — |
|
| Significant Related Party Transactions | — |
|
| Trade and Other Payables | — |
|
| Trade and Other Receivables | — |
|
| Warrant Liabilities and Warrant Reserve | — |
|